CN107602437A - 活化酯的制备方法 - Google Patents
活化酯的制备方法 Download PDFInfo
- Publication number
- CN107602437A CN107602437A CN201710676427.7A CN201710676427A CN107602437A CN 107602437 A CN107602437 A CN 107602437A CN 201710676427 A CN201710676427 A CN 201710676427A CN 107602437 A CN107602437 A CN 107602437A
- Authority
- CN
- China
- Prior art keywords
- acibenzolar
- reaction solution
- preparation
- petroleum ether
- silica gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CGIHPACLZJDCBQ-UHFFFAOYSA-N acibenzolar Chemical compound SC(=O)C1=CC=CC2=C1SN=N2 CGIHPACLZJDCBQ-UHFFFAOYSA-N 0.000 title claims abstract description 65
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000003960 organic solvent Substances 0.000 claims abstract description 33
- 239000002253 acid Substances 0.000 claims abstract description 19
- 239000003054 catalyst Substances 0.000 claims abstract description 16
- 125000001931 aliphatic group Chemical group 0.000 claims abstract description 15
- -1 hydroxyl amino structure Chemical group 0.000 claims abstract description 12
- 239000005416 organic matter Substances 0.000 claims abstract description 11
- 239000007795 chemical reaction product Substances 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 115
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 113
- 238000006243 chemical reaction Methods 0.000 claims description 91
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 58
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 51
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 47
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 45
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 43
- 239000000741 silica gel Substances 0.000 claims description 39
- 229910002027 silica gel Inorganic materials 0.000 claims description 39
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 33
- 239000003208 petroleum Substances 0.000 claims description 33
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 22
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 claims description 19
- 235000021360 Myristic acid Nutrition 0.000 claims description 19
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims description 19
- 239000003480 eluent Substances 0.000 claims description 17
- 238000002390 rotary evaporation Methods 0.000 claims description 17
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 15
- 239000011259 mixed solution Substances 0.000 claims description 14
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- 230000004913 activation Effects 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical class C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 239000012043 crude product Substances 0.000 claims description 4
- 238000001179 sorption measurement Methods 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 3
- CCMKPCBRNXKTKV-UHFFFAOYSA-N 1-hydroxy-5-sulfanylidenepyrrolidin-2-one Chemical class ON1C(=O)CCC1=S CCMKPCBRNXKTKV-UHFFFAOYSA-N 0.000 claims description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 239000010703 silicon Substances 0.000 claims description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N hydroxylamine group Chemical group NO AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims 1
- WHQSYGRFZMUQGQ-UHFFFAOYSA-N n,n-dimethylformamide;hydrate Chemical compound O.CN(C)C=O WHQSYGRFZMUQGQ-UHFFFAOYSA-N 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 23
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 abstract description 15
- 230000008569 process Effects 0.000 abstract description 7
- 230000009471 action Effects 0.000 abstract description 2
- 230000000087 stabilizing effect Effects 0.000 abstract description 2
- HKRXEYFECICKQF-UHFFFAOYSA-N 2-(2,5-dioxopyrrolidin-1-yl)tetradecanoic acid Chemical class CCCCCCCCCCCCC(C(O)=O)N1C(=O)CCC1=O HKRXEYFECICKQF-UHFFFAOYSA-N 0.000 abstract 1
- 230000003321 amplification Effects 0.000 abstract 1
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 1
- 229960001866 silicon dioxide Drugs 0.000 description 32
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 23
- 238000009833 condensation Methods 0.000 description 16
- 230000005494 condensation Effects 0.000 description 16
- 238000001514 detection method Methods 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 239000000047 product Substances 0.000 description 14
- 235000019441 ethanol Nutrition 0.000 description 12
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 11
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 238000005917 acylation reaction Methods 0.000 description 7
- 150000002170 ethers Chemical class 0.000 description 6
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 108010089308 Insulin Detemir Proteins 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 229960003948 insulin detemir Drugs 0.000 description 5
- UGOZVNFCFYTPAZ-IOXYNQHNSA-N levemir Chemical compound CCCCCCCCCCCCCC(=O)NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=2N=CNC=2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=2N=CNC=2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=2C=CC=CC=2)C(C)C)CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)CSSC[C@H](NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC2=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H](CSSC1)C(=O)N[C@@H](CC(N)=O)C(O)=O)CC1=CC=C(O)C=C1 UGOZVNFCFYTPAZ-IOXYNQHNSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 235000021314 Palmitic acid Nutrition 0.000 description 4
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 4
- 239000013557 residual solvent Substances 0.000 description 4
- 239000012295 chemical reaction liquid Substances 0.000 description 3
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical class ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 150000002466 imines Chemical class 0.000 description 3
- 238000010829 isocratic elution Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 230000010933 acylation Effects 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- IYLXCLAZLAWMIR-UHFFFAOYSA-N 1-hydroxypyrrolidine-2,5-dione;tetradecanoic acid Chemical compound ON1C(=O)CCC1=O.CCCCCCCCCCCCCC(O)=O IYLXCLAZLAWMIR-UHFFFAOYSA-N 0.000 description 1
- 108010092217 Long-Acting Insulin Proteins 0.000 description 1
- 102000016261 Long-Acting Insulin Human genes 0.000 description 1
- 229940100066 Long-acting insulin Drugs 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical class OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000220287 Sedum rubrotinctum Species 0.000 description 1
- DDFGTVSLZJLQEV-UHFFFAOYSA-N [C](C1CCCCC1)C1CCCCC1 Chemical compound [C](C1CCCCC1)C1CCCCC1 DDFGTVSLZJLQEV-UHFFFAOYSA-N 0.000 description 1
- MOFINMJRLYEONQ-UHFFFAOYSA-N [N].C=1C=CNC=1 Chemical class [N].C=1C=CNC=1 MOFINMJRLYEONQ-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000001343 alkyl silanes Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000003317 industrial substance Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- ZTUXEFFFLOVXQE-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCC(O)=O ZTUXEFFFLOVXQE-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710676427.7A CN107602437A (zh) | 2017-08-09 | 2017-08-09 | 活化酯的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710676427.7A CN107602437A (zh) | 2017-08-09 | 2017-08-09 | 活化酯的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107602437A true CN107602437A (zh) | 2018-01-19 |
Family
ID=61064576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710676427.7A Pending CN107602437A (zh) | 2017-08-09 | 2017-08-09 | 活化酯的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107602437A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01254699A (ja) * | 1988-04-05 | 1989-10-11 | Kodama Kk | インスリン誘導体及びその用途 |
CN1171742A (zh) * | 1994-11-17 | 1998-01-28 | 伊莱利利公司 | ε-氨基的选择性酰化 |
US20090137454A1 (en) * | 2006-02-27 | 2009-05-28 | Novo Nordisk A/S | Insulin Derivatives |
CN103272218A (zh) * | 2013-05-21 | 2013-09-04 | 首都医科大学 | 铜(ⅱ)-(脂肪酰甘氨酰天冬氨酰组氨酸)配合物的制备及其sod样活性研究 |
CN106083634A (zh) * | 2016-06-16 | 2016-11-09 | 淮阴师范学院 | 一种两亲性肽分子及其制备方法和应用 |
-
2017
- 2017-08-09 CN CN201710676427.7A patent/CN107602437A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01254699A (ja) * | 1988-04-05 | 1989-10-11 | Kodama Kk | インスリン誘導体及びその用途 |
CN1171742A (zh) * | 1994-11-17 | 1998-01-28 | 伊莱利利公司 | ε-氨基的选择性酰化 |
EP1227107A1 (en) * | 1994-11-17 | 2002-07-31 | Eli Lilly And Company | Selective acylation of E-amino groups |
US20090137454A1 (en) * | 2006-02-27 | 2009-05-28 | Novo Nordisk A/S | Insulin Derivatives |
CN103272218A (zh) * | 2013-05-21 | 2013-09-04 | 首都医科大学 | 铜(ⅱ)-(脂肪酰甘氨酰天冬氨酰组氨酸)配合物的制备及其sod样活性研究 |
CN106083634A (zh) * | 2016-06-16 | 2016-11-09 | 淮阴师范学院 | 一种两亲性肽分子及其制备方法和应用 |
Non-Patent Citations (5)
Title |
---|
BARBARA FAROUX-CORLAY等: "Amphiphilic Anionic Analogues of Galactosylceramide: Synthesis, Anti-HIV-1 Activity, and gp120 Binding", 《JOURNAL OF MEDICINAL CHEMISTRY》 * |
SAUBHIK HALDAR等: "A systematic understanding of gelation self-assembly: solvophobically assisted supramolecular gelation via conformational reorientation across amide functionality on a hydrophobically modulated dipeptide based ambidextrous gelator, N-n-acyl-(L)Val-X(OBn)", 《RSC ADVANCES》 * |
Y. LAPIDOT等: "Use of esters of N-hydroxysuccinimide in the synthesis of N-acylamino acids", 《JOURNAL OF LIPID RESEARCH》 * |
刘海峰: "重组胰岛素前体转化成人胰岛素和地特胰岛素的工艺研究", 《华东理工大学博士学位论文》 * |
汪世龙: "《蛋白质化学》", 31 August 2012, 同济大学出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nambara et al. | High-pressure liquid chromatographic resolution of amino acid enantiomers by derivatization wtth'new chiral reagents | |
Goto et al. | Sensitive derivatizatton reagents for the resolution of carboxylic acid enantiomers by high-performance liquid chromatography | |
CN111690036A (zh) | 一种高效抗肿瘤活性多肽Tubulysin M的制备方法 | |
CN107141250A (zh) | 一种用于细胞荧光显色的水溶性荧光染料 | |
CN109265464A (zh) | 一种手性共价有机框架材料及其制备方法和应用 | |
CN104927044A (zh) | 高纯度聚乙二醇醛类衍生物的制备方法 | |
CN107287029B (zh) | 一种碘化植物油脂肪酸乙酯的制备方法 | |
CN108144326A (zh) | 一种基于阴离子型金属有机骨架材料高效分离有机染料的方法 | |
CN101195598A (zh) | 麦根酸类的高效制造方法 | |
CN107973785B (zh) | 一种用于检测银离子的荧光探针及其制备方法和应用 | |
CN107602437A (zh) | 活化酯的制备方法 | |
CN108409978A (zh) | 一种可快捷检测巯基氨基酸的金属-有机框架及其制备方法 | |
CN101973879B (zh) | 一种吉法酯的制备方法 | |
CN104569372B (zh) | 一种隐性孔雀石绿半抗原的制备方法 | |
CN107778297A (zh) | 氘代脱氢苯基阿夕斯丁类化合物的多晶型及其制备方法和应用 | |
CN104945468B (zh) | Mmaf手性异构体的制备方法及其应用 | |
CN102212075A (zh) | 头孢拉宗的制备方法 | |
CN105268415A (zh) | 一种固相萃取填料及其在测定食品中磺胺残留的应用 | |
CN106831788A (zh) | 伊布替尼精制方法 | |
CN104045680A (zh) | 桦木醇的乙酰氨基酸酰类衍生物及其制备方法 | |
CN104628892B (zh) | 6‑苄基苯乙胺衍生化β‑环糊精键合SBA‑15的制备方法及用途 | |
CN1657517A (zh) | 新鱼腥草素钠的合成方法 | |
Peng et al. | Preparation and prodrug studies of quercetin pentabenzensulfonate | |
CN106397188A (zh) | 一种l‑菊苣酸的制备方法 | |
CN103044448B (zh) | 一种他唑巴坦的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210121 Address after: 200237 room 08, 20 / F, South Building, 333 Chengdu North Road, Jing'an District, Shanghai Applicant after: SHANGHAI ANGDE BIOLOGICAL TECHNOLOGY Co.,Ltd. Applicant after: Huarun Onde Biopharmaceutical Co.,Ltd. Address before: 200237 room 08, 20 / F, South Building, 333 Chengdu North Road, Jing'an District, Shanghai Applicant before: SHANGHAI ANGDE BIOLOGICAL TECHNOLOGY Co.,Ltd. Applicant before: Dong-e E-jiao Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180119 |
|
RJ01 | Rejection of invention patent application after publication |